Cortexyme, Inc. insider trading activity
Understanding Insider Activity at Cortexyme, Inc.
Welcome to our dedicated page for Cortexyme, Inc. (Nasdaq: QNCX) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by Cortexyme, Inc.'s key insiders, providing a unique window into the company's internal sentiments.
How to Use This Data:
Below, you can view insider transactions that were reported to the SEC within the last 365 days.
While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.
Scroll down to view the most recent insider transactions for Cortexyme, Inc., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.
Track insider trades for QNCX| Ticker | Time & Date | Filing | Link |
|---|---|---|---|
| QNCX | 9:38:44 PM, 9/3/2024 | Thye Dirk(CEO AND CHIEF MEDICAL OFFICER) purchased 154500 shares of Quince Therapeutics, Inc. (QNCX) for ~$107374 | Filing |
| QNCX | 9:51:16 PM, 8/22/2024 | Ryan Charles S.(PRESIDENT) purchased 48387 shares of Quince Therapeutics, Inc. (QNCX) for ~$31451 | Filing |
| QNCX | 10:38:07 PM, 8/21/2024 | Hannah Brendan(CHIEF BUSINESS OFFICER AND COO) purchased 38924 shares of Quince Therapeutics, Inc. (QNCX) for ~$24163 | Filing |
| QNCX | 11:21:33 PM, 12/14/2023 | Lamond David purchased 67881 shares of Quince Therapeutics, Inc. (QNCX) for ~$69232 | Filing |
| QNCX | 11:30:10 PM, 12/7/2023 | Lamond David purchased 57369 shares of Quince Therapeutics, Inc. (QNCX) for ~$58133 | Filing |
| QNCX | 6:38:01 PM, 12/1/2023 | Lamond David purchased 43134 shares of Quince Therapeutics, Inc. (QNCX) for ~$40545 | Filing |
| QNCX | 10:42:15 PM, 8/31/2023 | Lamond David purchased 82052 shares of Quince Therapeutics, Inc. (QNCX) for ~$107898 | Filing |
| QNCX | 10:08:21 PM, 8/17/2023 | Lamond David purchased 250000 shares of Quince Therapeutics, Inc. (QNCX) for ~$325735 | Filing |
| QNCX | 8:15:34 PM, 8/11/2023 | Thye Dirk(Chief Executive Officer) purchased 88000 shares of Quince Therapeutics, Inc. (QNCX) for ~$110880 | Filing |
| QNCX | 10:23:31 PM, 8/9/2023 | Thye Dirk(Chief Executive Officer) purchased 80000 shares of Quince Therapeutics, Inc. (QNCX) for ~$99200 | Filing |
| QNCX | 10:21:38 PM, 8/9/2023 | Hannah Brendan(Chief Business Officer) purchased 71762 shares of Quince Therapeutics, Inc. (QNCX) for ~$87549 | Filing |
| QNCX | 10:18:36 PM, 8/9/2023 | McLoughlin Margaret purchased 8000 shares of Quince Therapeutics, Inc. (QNCX) for ~$9840 | Filing |
| QNCX | 11:55:56 PM 3/6/2023 | Monohon Ted(Chief Accounting Officer & VP) sold 1871 shares of Quince Therapeutics, Inc. (QNCX) for ~$1833 | Filing |
Discover the Complete Picture 🔒
Currently viewing just 6 of 13 insider filings.
Register now to dive deeper and explore the full dataset.